This fact sheet describes PATH's enteric vaccine project from a technical perspective. It includes an overview of PATH's vaccine development portfolio, research activities, and partners to support the development of effective and affordable vaccines against Shigella and enterotoxigenic Escherichia coli, the leading bacterial causes of diarrhea, for children in the developing world.

Corporate author(s): PATH

Publication date: October 2013

Available materials


Innovation in Enteric Vaccine Development

618 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series Diarrheal disease fact sheets

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA